BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/8/2024 4:58:17 AM | Browse: 104 | Download: 241
 |
Received |
|
2024-01-10 14:18 |
|
Peer-Review Started |
|
2024-01-10 14:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-13 05:51 |
|
Revised |
|
2024-05-31 14:40 |
|
Second Decision |
|
2024-06-21 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-21 06:02 |
|
Articles in Press |
|
2024-06-21 06:02 |
|
Publication Fee Transferred |
|
2024-06-24 13:22 |
|
Edit the Manuscript by Language Editor |
|
2024-07-02 05:16 |
|
Typeset the Manuscript |
|
2024-07-10 02:24 |
|
Publish the Manuscript Online |
|
2024-08-08 04:58 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wu-Jie Wei, Ya-Li Hong, Yi Deng, Guan-Liang Wang, Jiang-Tao Qiu and Fang Pan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fang Pan, N/A, Doctor, Doctor, Department of Oncology, People's Hospital of Chongqing Hechuan, No. 1366 Hill'an Avenue, Nanjin Street Office, Hechuan District, Chongqing 401520, China. panfang124@163.com |
| Key Words |
Targeted therapy; Hepatocyte growth factor and its receptor; Gastric cancer; Prognosis assessment; Review |
| Core Tip |
Hepatocyte growth factor (HGF) and its receptor, c-Met, play important roles in the occurrence, development, and treatment of gastric cancer (GC). This review aimed to explore the function of the HGF/c-Met signaling pathway in GC and its potential targeted therapeutic mechanisms. As one of the most common malignant tumors in the world, GC has a complex pathogenesis and limited therapeutic options. Therefore, a thorough understanding of the molecular mechanism of GC is very important for the development of new therapeutic methods. The HGF/c-Met signaling pathway plays an important role in the proliferation, migration, and invasion of GC cells and has become a new therapeutic target. |
| Publish Date |
2024-08-08 04:58 |
| Citation |
<p>Wei WJ, Hong YL, Deng Y, Wang GL, Qiu JT, Pan F. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review. <i>World J Gastrointest Oncol</i> 2024; 16(8): 3397-3409</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i8/3397.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i8.3397 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
